Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: BUCAPSOL — Original Application (PANGEA PHARMACEUTICALS, LLC)

View source ↗

Summary

FDA approved BUCAPSOL, a generic buspirone hydrochloride product, under an Original Abbreviated New Drug Application by PANGEA PHARMACEUTICALS, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUCAPSOL (buspirone hydrochloride)

Snippet

ORIG AP for BUCAPSOL (BUSPIRONE HYDROCHLORIDE)